ID

22332

Beskrivning

A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD) Medicine: rosiglitazone, Condition: Alzheimer's Disease, Phase: 2, Clinical Study ID: 49653/461, Sponsor: GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1

Länk

https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1

Nyckelord

Versioner (1)
  1. 2017-05-30 2017-05-30 -
Uppladdad den

30 maj 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Pregnancy Information Study Conclusion Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

Engelsk

Pregnancy Information Study Conclusion Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

1 Formulär  
Pregnancy Information
Beskrivning

Pregnancy Information

Alias
UMLS CUI-1
C0032961
UMLS CUI-2
C1533716
Did patient become pregnant during the study? (mark one box below) -> If "yes" record details on Pregnancy Notification Form
Beskrivning

Pregnancy

Datatyp

integer

Alias
UMLS CUI [1]
C0032961
Did the female partner of a male patient become pregnant during the study? (mark one box below) --> if "yes" record details on Pregnancy Notification Form.
Beskrivning

Female of childbearing potential

Datatyp

integer

Alias
UMLS CUI [1]
C1960468
Study Conclusion
Beskrivning

Study Conclusion

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0008972
Did the patient complete the study as planned?
Beskrivning

Study completion

Datatyp

boolean

Alias
UMLS CUI [1]
C2826674
If "no", mark the one most appropriate category
Beskrivning

Specification

Datatyp

integer

Alias
UMLS CUI [1]
C2348235
Please specify "Other"
Beskrivning

Other diseases

Datatyp

text

Alias
UMLS CUI [1]
C2359476
Comments on reason for withdrawal:
Beskrivning

Withdrawal

Datatyp

text

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0392360
Date of Withdrawal
Beskrivning

Date of Withdrawal

Datatyp

date

Måttenheter
  • dd/mm/yyyy
Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0011008
dd/mm/yyyy
Time of Withdrawal
Beskrivning

Time of Withdrawal

Datatyp

time

Måttenheter
  • hr:min
Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0040223
hr:min
Date of Final Dose:
Beskrivning

therapy end date

Datatyp

date

Måttenheter
  • dd/mm/yyyy
Alias
UMLS CUI [1]
C1531784
dd/mm/yyyy
Time of Final Dose
Beskrivning

Pharmaceutical Preparations

Datatyp

time

Måttenheter
  • hr:min
Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C1522314
hr:min
Tillbaka till toppen

Similar models

Pregnancy Information Study Conclusion Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Pregnancy Information
C0032961 (UMLS CUI-1)
C1533716 (UMLS CUI-2)
Item
Did patient become pregnant during the study? (mark one box below) -> If "yes" record details on Pregnancy Notification Form
integer
C0032961 (UMLS CUI [1])
Pregnancy
Code List
Did patient become pregnant during the study? (mark one box below) -> If "yes" record details on Pregnancy Notification Form
CL Item
Not applicable (not of childbearing potential) (1)
CL Item
No (2)
CL Item
Yes (3)
Item
Did the female partner of a male patient become pregnant during the study? (mark one box below) --> if "yes" record details on Pregnancy Notification Form.
integer
C1960468 (UMLS CUI [1])
Female of childbearing potential
Code List
Did the female partner of a male patient become pregnant during the study? (mark one box below) --> if "yes" record details on Pregnancy Notification Form.
CL Item
Not applicable (subject is female, female partner not of childbearing potential or female partner) (1)
CL Item
No (2)
CL Item
Yes (3)
Item Group
Study Conclusion
C1707478 (UMLS CUI-1)
C0008972 (UMLS CUI-2)
Study completion
Item
Did the patient complete the study as planned?
boolean
C2826674 (UMLS CUI [1])
Item
If "no", mark the one most appropriate category
integer
C2348235 (UMLS CUI [1])
Specification
Code List
If "no", mark the one most appropriate category
CL Item
Adverse Event (complete Adverse Event Form) (1)
CL Item
Insufficient therapeutic effect (2)
CL Item
Deviation from Protocol (including non-compliance) (3)
CL Item
Lost to Follow-Up (4)
CL Item
Other (5)
Other diseases
Item
Please specify "Other"
text
C2359476 (UMLS CUI [1])
Withdrawal
Item
Comments on reason for withdrawal:
text
C2349954 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
Date of Withdrawal
Item
Date of Withdrawal
date
C2349954 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Time of Withdrawal
Item
Time of Withdrawal
time
C2349954 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
therapy end date
Item
Date of Final Dose:
date
C1531784 (UMLS CUI [1])
Pharmaceutical Preparations
Item
Time of Final Dose
time
C0013227 (UMLS CUI [1,1])
C1522314 (UMLS CUI [1,2])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial